Get started
Author

Carol Anthony

OpenAlex ID: A5113787957
Use, misuse, and overuse of white cell growth factors (GF) in community oncology practices in southeastern United States.
2014 · William J. Hrushesky, Dinah Faith Q Huff, et al. · Journal of Clinical Oncology · 4
Community use of anthracyclines in metastatic breast cancer (MBC).
2013 · James Edward Krook, Akhil Kumar, et al. · Journal of Clinical Oncology · 1
Community platinum use in neoadjuvant or adjuvant HER2- breast cancer.
2015 · Laura Rose Bobolts, Melissa Armitage, et al. · Journal of Clinical Oncology
Adjuvant colon cancer care compliance with level I data and NCCN guidelines in the elderly population.
2014 · Anmol Baranwal, Dinah Faith Q Huff, et al. · Journal of Clinical Oncology
Effect of Oncology Analytics (OA) cancer care quality initiative on inappropriate use of erythropoiesis stimulating agents (ESA) among cancer patients receiving chemotherapy with curative intent.
2014 · William J. Hrushesky, Charles L. Bennett, et al. · Journal of Clinical Oncology
Improving QOL and safety while reducing costs: Evidence-based adjuvant chemotherapy of colorectal cancer (CRC).
2013 · William S. Shimp, Akhil Kumar, et al. · Journal of Clinical Oncology
Off-label capecitabine, eribulin, or ixabepilone use in metastatic breast cancer (MBC).
2013 · Laura Rose Bobolts, Akhil Kumar, et al. · Journal of Clinical Oncology
Community use of anthracyclines for adjuvant HER2-positive breast cancer (BC).
2013 · Akhil Kumar, Marc L. Fishman, et al. · Journal of Clinical Oncology
Annual rhythm in filgrastim use in southeast Florida.
2013 · Dinah Huff, William J. Hrushesky, et al. · Journal of Clinical Oncology
Trends in the use of bone agents in metastatic cancer.
2013 · Jurgen Wilhelm Kogler, William J. Hrushesky, et al. · Journal of Clinical Oncology
Building the office team: what's the payoff?
2007 · Carol Anthony, Karen Marcelo · PubMed
Works count: 11
Citation count: 5
H-index: 1
I10-index:
Year
Topic
Type